Answers are grounded in this paper and cite their sources.
// Mingyu Du 1, 4, * , Teng Huang 2, * , Jing Wu 4 , Jia-Jia Gu 4 , Nan Zhang 4 , Kai Ding 1 , Lu-Xi Qian 3 , Zhi-Wei Lu 3 , Wen-Jun Zhang 3 , Xiao-Kang Tian 1 , Xia He 1, 4 and Li Yin 4 1 Xuzhou Medical University, Xuzhou, Jiangsu, China 2 Department of Radiation Oncology, Jiangsu Province Hospital of TCM, Nanjing, Jiangsu, China 3 The Fourth Clinical Medical College of Nanjing Medical University, Nanjing, Jiangsu, China 4 Jiangsu Cancer Hospital and Jiangsu Institue of Cancer Research and Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, China * These authors contributed equally to this work Correspondence to: Xia He, email: hexiabm@163.com Li Yin, email: yinli_2012@126.com Keywords: nasopharyngeal carcinoma; lncRNA-n326322; invasion Received: May 01, 2017 Accepted: November 05, 2017 Published: December 01, 2017 ABSTRACT Long non-coding RNAs (lncRNAs) have been reported to perform significant roles in cancer development and progression. Our research has found that a novel lncRNA n326322 was higher in nasopharyngeal carcinoma (NPC) cells. Moreover, the gain and loss of functional approaches revealed that the overexpression of lncRNA-n326322 promoted NPC cell proliferation and invasion, whereas the downregulation of lncRNA-n326322 suppressed cell proliferation and invasion. Further experiments demonstrated that potential mechanism may be associated with the activation of PI3K/AKT and ERK/MAPK pathways. Taken together, these results indicate that lncRNA-n326322 is associated with tumorigenesis of NPC.
No takes yet. Share an insight, caveat, or question.
Du et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: